Kyoto, Japan

Mitsuo Nakamura


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1983-1984

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mitsuo Nakamura: Innovator in Anti-Tumor Agents

Introduction

Mitsuo Nakamura is a distinguished inventor based in Kyoto, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-tumor agents. With a total of 2 patents, his work has the potential to impact cancer treatment significantly.

Latest Patents

Nakamura's latest patents include innovative ester derivatives of alkoxybenzoyldeoxyfluorouridine. These new derivatives are characterized by a general formula wherein R represents an alkoxy group with 1 to 4 carbon atoms. The compounds are prepared by acylating a 2'-deoxy-3',5'-di-O-alkylcarbonyl-5-fluorouridine with corresponding benzoyl halides. They are particularly useful as active ingredients for anti-tumor agents, especially for oral administration. Another notable patent involves ester derivatives of deoxyfluorouridine, which are also prepared through a similar acylation process and serve as active ingredients for anti-tumor agents.

Career Highlights

Throughout his career, Mitsuo Nakamura has worked with notable companies such as Funai Kakuhin Kogyo and Funai Yakuhin Kogyo. His experience in these organizations has contributed to his expertise in the field of pharmaceuticals and medicinal chemistry.

Collaborations

Nakamura has collaborated with esteemed colleagues, including Setsuro Fujii and Bompei Yasui. These partnerships have fostered innovation and advancement in his research endeavors.

Conclusion

Mitsuo Nakamura's contributions to the development of anti-tumor agents through his innovative patents highlight his role as a key figure in medicinal chemistry. His work continues to pave the way for advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…